Global Atopic Dermatitis Market: By Disease Severity (Mild, Moderate, and Severe), By Treatment Type (Corticosteroids, Antihistamines, Calcineurin Inhibitors, Immunomodulators, Biologic Therapy, PDE-4 Inhibitor, Antibiotics, Moisturizers/Emollients, and Off-Label Therapies); By Distribution Channel (Hospitals, Dermatology Clinics, Retail Pharmacy, and Online Pharmacy); By Geography – Forecast (2018 - 2025)

January 2019

 Pages: 125

 ERC 9722


Global Atopic Dermatitis Market Overview

Atopic dermatitis (AD) is a type of skin disorder in which the skin becomes dry, itchy and inflamed. Scratching of the skin leads to, swelling, scaling, cracking, weeping, redness and crusting. Though this condition is most common in children, also affects the adult population. Generally, people with AD develop hay fever.

The Global Atopic Dermatitis Market was worth USD XX billion in 2017 and is forecasted to reach USD XX billion by 2025, growing at a CAGR of XX% during the forecast period (2018-2025).

Global Atopic Dermatitis Market– Market Dynamics

An increasing number of pipeline products for atopic dermatitis is one of the major driving factor leading to the growth of the market. The pipeline of more targeted topical and systemic therapies is expanding based on growing demand for unmet treatment of AD. The pipeline for atopic dermatitis is impressive with the majority of drugs in stage III and II. Once launched upon the successful completion of the development cycle, these drugs will boost the market growth significantly.

On the other side, The treatment of Atopic dermatitis consists of emollient therapy, and daily skin hydration, but the majority of patients still require symptomatic treatment with corticosteroids and calcineurin inhibitors,  which are associated with potential long-term side effects. Some side effects of topical treatment include- atrophy (the skin becomes thin), lichenification (the skin becomes thick, stretch marks and skin darkening.

Global Atopic Dermatitis Market– Segment Analysis

Based on the distribution channel the market is segmented into Hospitals, Dermatology Clinics, Retail Pharmacy, and Online Pharmacy. Of these, the hospital segment is the largest segment in 2017. Further, The pharmacy department in hospital under the direction of a qualified pharmacist is responsible for the procurement, storage, and distribution of medication throughout the hospital. The sale of atopic dermatitis drugs in hospitals is relatively low compared with retail channels. However, in emerging markets, pharma companies promote their drugs through physicians and hospitals due to lack of awareness among end-users about the prescription.

 Global Atopic Dermatitis Market– Geographical Analysis

Geographically, the Global Atopic Dermatitis Market is segmented into Asia-Pacific, North America, Europe, South America, and RoW. Of these, North America is expected to account for the largest market share for the atopic dermatitis market owing to several factors such as high treatment awareness among the patient population across US and Canada, early adoption of novel medications, and healthcare infrastructure. Healthcare organizations with Established Clinical guidelines, improved care and appropriate standards for dermatological diseases is supporting the growth of Atopic Dermatitis market in the North American region.

Europe holds the second largest market share, owing to the government support for research & development and availability. This is expected to drive the European market over the forecasted period. For instance, countries like France and Germany are increasing investment in the healthcare domain.

Global Atopic Dermatitis Market– Competitive Analysis

The Global Atopic Dermatitis Market products are fragmented with a large number of local and international players. However, Some of the most important manufacturersand suppliers of the atopic dermatitis market are LEO Pharma, Mylan, Novartis, Pfizer, Inc, Sanofi, and Valeant. These companies are mostly focused on the capacity of expansion due to increasing demand for atopic dermatitis in various industries. For instance, in February 2018, Sanofi has launched Dupixent™ in Canada for treating moderate-to-severe atopic dermatitis (AD) in adults.

Global Atopic Dermatitis Market Segmentation:

  • By Disease Severity
    • Mild
    • Moderate
    • Severe
  • By Treatment Type
    • Corticosteroids
    • Antihistamines
    • Calcineurin Inhibitors
    • Immunomodulators
    • Biologic Therapy
    • PDE-4 Inhibitor
    • Antibiotics
    • Moisturizers/Emollients
    • Off-Label Therapies
  • By Distribution Channel
    • Hospitals
    • Dermatology Clinics
    • Retail Pharmacy
    • Online Pharmacy
  • Company Profiles
    • LEO Pharma
    • Mylan
    • Novartis
    • Pfizer, Inc
    • Sanofi
    • Valeant
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • RoW
Please fill in the form below to Request for Customized Report
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

    • What was the market size of the Active Pharmaceutical Ingredients Market in 2017 and the expected market size by 2025, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2017 - 2025)?
    • Which are the leading companies in the Active Pharmaceutical Ingredients Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

Purchase Options

Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities


  • We offer 20% free customization on every purchase.

Get in touch!